Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort

Eitemau Tebyg

• Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF‐β and PD‐L1
  gan: Vugmeyster, Yulia, et al.
  Cyhoeddwyd: (2020)
• Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
  gan: Paz-Ares, Luis, et al.
  Cyhoeddwyd: (2020)
• Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort
  gan: Cho, Byoung Chul, et al.
  Cyhoeddwyd: (2020)
• Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia
  gan: Lin, Chia-Chi, et al.
  Cyhoeddwyd: (2021)
• Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
  gan: Strauss, Julius, et al.
  Cyhoeddwyd: (2020)